4//SEC Filing
Smith W Bradford 4
Accession 0000899243-21-005458
CIK 0001661998other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:22 PM ET
Size
14.1 KB
Accession
0000899243-21-005458
Insider Transaction Report
Form 4
Smith W Bradford
CFO, Treasurer & Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-02-08$0.64/sh+13,500$8,640→ 13,500 total - Award
Restricted Stock Units
2021-02-05+20,000→ 20,000 total→ Common Stock (20,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-02-08−13,500→ 101,904 totalExercise: $0.64Exp: 2027-04-05→ Common Stock (13,500 underlying) - Sale
Common Stock
2021-02-08$14.25/sh−13,500$192,425→ 0 total - Award
Employee Stock Option (Right to Buy)
2021-02-05+122,000→ 122,000 totalExercise: $13.78Exp: 2031-02-05→ Common Stock (122,000 underlying)
Footnotes (6)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $14.00 to $14.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F5]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.
- [F6]The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001317678
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:22 PM ET
- Size
- 14.1 KB